NVO
Novo Nordisk A/SANYSE / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
+
Peers tracked
10
U.S. public peers
Grade Position
Above peers
vs peer average
NVO vs peer average
77/100
NVO vs. peer average (A vs. C)
Grade spread
A 2 · B 3 · C 2 · D 2 · F 1
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
LLY is the first available peer comparator.
Closest commercial obesity and diabetes competitor; the cleanest read-through on U.S. pricing, access, and category share for Novo's Wegovy franchise.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
NVO
Novo Nordisk A/S
LLY
Eli Lilly and
Grade
A
A
Momentum
23
40
Value
66
60
Sentiment
81
83
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Constructive
Grade position vs LLY
NVO / LLY
Grade Position
Above peers
NVO vs. peer average (A vs. C)
77/100
Momentum
23
LLYValue
66
NVOSentiment
81
LLYRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs NVO
LLY is the first peer returned for this comparison set.